CAS 361442-04-8 Maʻemaʻe >99.0% (HPLC) API

ʻO ka wehewehe pōkole:

Nā huaʻōlelo like: BMS-477118;ʻO Onglyza

CAS: 361442-04-8

Maʻemaʻe: >99.0% (HPLC)

Nānā: Pada Keʻokeʻo

API, Mea Kiʻekiʻe, Hana Kalepa

E-Mail: alvin@ruifuchem.com


Huahana Huahana

Nā Huahana Pili

Huahana Huahana

wehewehe:

Na Waiwai Kemika:

Nā huaʻōlelo like BMS-477118;Onglyza;(1S,3S,5S)-2-[(2S)-2-Amino-2-(3-Hydroxy-1-Adamantyl)acetyl]-2-Azabicyclo[3.1.0]hexane-3-Carbonitrile;(1S,3S,5S)-2-[(2S)-2-Amino-2-(3-Hydroxytricyclo [3.3.1.13,7]dec-1-yl)acetyl]-2-Azabicyclo[3.1.0]hexane -3-Carbonitrile
Helu CAS 361442-04-8
Helu CAT RF-PI1991
Kūlana Kūʻai Ma ka waihona, hoʻonui ʻia a hiki i nā tona
ʻĀpana Molekala C18H25N3O2
Kaumaha Molecular 315.41
Brand Kemika Ruifu

Nā kikoʻī:

'ikamu Nā kikoʻī
Ka nana aku Pauda keʻokeʻo
ʻala ʻano ʻano
ʻike ʻike A: IR B: Manawa Paʻa HPLC
Maʻemaʻe / Kaʻina Hanana >99.0% (HPLC)
Malamalama o ka Wai Alohilohi, kala ʻole, ʻaʻohe mea i hoʻopaʻa ʻia
Anana Anaina 100% Holo i ka 80 Mesh
Lae hehee 202.0~212.0 ℃
Nalo ma ka maloo <0.50%
Lehu Sulphated <0.20%
Hoʻololi kikoʻī +174.0°~+186.0°
Hoʻokahi haumia <0.50%
Huina paumaele <1.00%
Nā Metala Kaumaha <10ppm
Arsenic (As) <2.0ppm
Ke kēpau (Pb) <1.0ppm
Cadmium (Cd) <1.0ppm
Nā mea hoʻoheheʻe koena <100ppm
Pesticide koena ʻinoʻino
Microbiology  
Huina Papa <1000cfu/g
Huna & Mold <100cfu/g
E. Coli ʻinoʻino
S. Aureus ʻinoʻino
Salmonella ʻinoʻino
Ola Pahu 24 mau mahina mai ka lā hana inā mālama pono ʻia
Kūlana hoʻāʻo Kūlana ʻoihana
Hoʻohana API;ʻO ka maʻi maʻi diabetes type 2

Pūʻolo a me ka waiho ʻana:

Pūʻolo: ʻOmole, ʻeke ʻeke Aluminum, 25kg / pahu pahu pahu, a i ʻole e like me ka makemake o ka mea kūʻai aku.

Kūlana mālama:E mālama i loko o nā pahu i hoʻopaʻa ʻia ma kahi maloʻo a maloʻo;E pale i ka malamalama a me ka wai

Pono:

1

FAQ:

Noi:

(BMS-477118) (CAS: 361442-04-8) he mea ikaika, koho, hoʻololi, hoʻokūkū a me ka waha i ka dipeptidyl peptidase-4 (DPP-4) (Ki = 0.6-1.3 nM) mea hoʻonā.Loaʻa iā BMS-477118 ka peotential no ka noiʻi maʻi diabetes type 2.BMS-477118he lāʻau maʻi diabetes type 2 hiki ke hoʻoulu i ka pancreas e hana hou aku i ka insulin ma hope o ka ʻai ʻana.Ua hōʻea ʻia e ka hui pū ʻana o AstraZeneca a me Bristol-Myers Squibb Company a nona ka DPP-IV inhibitor.BMS-477118pāʻani i ka hana ma o ka pale ʻana i ka hoʻohaʻahaʻa GLP-l.ʻO GLP-I nā hormones i hana maoli ʻia i loko o ka ʻōpū ma hope o ka ʻai ʻana i ka meaʻai.Hiki iā ia ke hoʻoponopono i ka huna ʻana o ka insulin a hoʻoikaika i ka hoʻohana ʻana i ka glucose i loko o nā ʻiʻo peripheral.Hiki i ka lāʻau lapaʻau hoʻokahi o BMS-477118 ke hoʻomaikaʻi i ka mana glucose koko a me ka lāʻau lapaʻau hui pū ʻia o BMS-477118 me Metformin, Sulfonylurea a me Thiazolidinediones hiki ke hoʻonui i ka hopena curative.Ke alakaʻi nei ia i ka haʻahaʻa haʻahaʻa o ka hypoglycemia a me kāna mau hopena ʻino e like me ka placebo, e hōʻike ana i ka hoʻomanawanui ʻoi aku ka maikaʻi.Ma Iulai 31, 2009, BMS-477118 nā papa (Onglyza), he lāʻau lapaʻau hou o ka maʻi diabetes type 2, i noiʻi pū ʻia a hoʻomohala ʻia ʻo AstraZeneca a me Bristol-Myers Squibb i ʻae ʻia e ka US FDA.Hiki ke lawe ʻia i hoʻokahi lā no ka mālama ʻana i ka maʻi diabetes type 2 i hui pū ʻia me ka mālama ʻana i ka meaʻai a me ka hoʻoikaika kino.

E kākau i kāu leka ma aneʻi a hoʻouna mai iā mākou